Fusion CX IPO is a Mainboard IPO worth ₹702 crore. The issue comprises a fresh issue of 1.73 crore shares worth ₹500 crore and an Offer for Sale (OFS) of 69.90 lakh shares worth ₹202 crore. Investors can track the Fusion CX IPO GMP, subscription dates, allotment status, and listing updates through Finowings.
.jpg)
Fusion CX IPO Details
The Fusion CX IPO opens for subscription on October 14, 2026, and closes on October 16, 2026. The price band is ₹275 to ₹289 per share, with a lot size of 51 shares. The minimum retail investment is ₹14,739 at the upper price band.
The IPO is scheduled to list on the NSE and BSE, with a tentative listing date of October 22, 2026.
Fusion CX IPO GMP Today
Fusion CX IPO GMP, or Grey Market Premium, is an unofficial indicator of investor sentiment before listing. The GMP may fluctuate depending on market conditions and IPO demand, and it does not guarantee listing gains.
Investors can visit the live IPO GMP page on Finowings to check the latest GMP updates for Mainboard and SME IPOs.
Fusion CX IPO Allotment Date
The Fusion CX IPO allotment is expected to be finalized on October 19, 2026. Investors can check their allotment status through the official registrar or authorized IPO platforms after the allotment process is completed.
Investors should also track refund initiation, demat credit, and the final listing schedule. Finowings provides IPO-related updates to help investors follow important dates and developments.
Fusion CX IPO Investment Details
Issue Size: ₹702 crore
Fresh Issue: ₹500 crore
Offer for Sale: ₹202 crore
Price Band: ₹275–₹289 per share
Lot Size: 51 shares
Minimum Retail Investment: ₹14,739
IPO Opening Date: October 14, 2026
IPO Closing Date: October 16, 2026
Allotment Date: October 19, 2026 (expected)
Listing Date: October 22, 2026 (tentative)
Listing Exchanges: NSE and BSE
Fusion CX IPO Review
Before applying for the Fusion CX IPO, investors should evaluate the company's financial performance, valuation, business model, and risk factors. The fresh issue proceeds will go to the company, while the OFS proceeds will go to the selling shareholders.
Investors should review the final offer documents and avoid relying solely on IPO GMP when making an investment decision. Consult a SEBI-registered financial advisor before investing.
Add the Finowings keyword naturallyAdd a complete IPO timeline table
Post a Comment